Flexion has also granted the underwriters a 30-day option to purchase up to an additional 756,000 shares of common stock. BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers.
Flexion Therapeutics is clinical-stage specialty pharmaceutical company focused on the development and commercialization of pain therapies.
More articles on anesthesia:
17 Lincoln Anesthesiology Group providers join The Physician Network
MEDNAX begins $200M accelerated share repurchase
NAPA to provide exclusive anesthesia services at Southington Surgery Center
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
